Out-of-Hospital Administration of Intravenous Glucose-Insulin-Potassium in Patients With Suspected Acute Coronary Syndromes | Zendy

Harry P. Selker | Zendy; Joni R. Beshansky | Zendy; Patricia Sheehan | Zendy; Joseph M. Massaro | Zendy; John L. Griffith | Zendy; Ralph B. D’Agostino | Zendy; Robin Ruthazer | Zendy; James M. Atkins | Zendy; Assaad Sayah | Zendy; Michael Levy | Zendy; Michael Richards | Zendy; Tom P. Aufderheide | Zendy; Darren Braude | Zendy; Ronald G. Pirrallo | Zendy; Delanor D. Doyle | Zendy; Ralph J. Frascone | Zendy; Donald J. Kosiak | Zendy; James M. Leaming | Zendy; Carin M. Van Gelder | Zendy; Gert Paul Walter | Zendy; Marvin A. Wayne | Zendy; Robert Woolard | Zendy; Lionel H. Opie | Zendy; Charles E. Rackley | Zendy; Carl S. Apstein | Zendy; James E. Udelson | Zendy

Open Access

Out-of-Hospital Administration of Intravenous Glucose-Insulin-Potassium in Patients With Suspected Acute Coronary Syndromes

Author(s) -

Harry P. Selker,

Joni R. Beshansky,

Patricia Sheehan,

Joseph M. Massaro,

John L. Griffith,

Ralph B. D’Agostino,

Robin Ruthazer,

James M. Atkins,

Assaad Sayah,

Michael Levy,

Michael Richards,

Tom P. Aufderheide,

Darren Braude,

Ronald G. Pirrallo,

Delanor D. Doyle,

Ralph J. Frascone,

Donald J. Kosiak,

James M. Leaming,

Carin M. Van Gelder,

Gert Paul Walter,

Marvin A. Wayne,

Robert Woolard,

Lionel H. Opie,

Charles E. Rackley,

Carl S. Apstein,

James E. Udelson

Publication year - 2012

Publication title -

jama

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.688

H-Index - 680

eISSN - 1538-3598

pISSN - 0098-7484

DOI - 10.1001/jama.2012.426

Subject(s) - medicine , myocardial infarction , placebo , hazard ratio , randomized controlled trial , clinical endpoint , emergency medical services , emergency department , odds ratio , acute coronary syndrome , emergency medicine , anesthesia , cardiology , confidence interval , alternative medicine , pathology , psychiatry

Laboratory studies suggest that in the setting of cardiac ischemia, immediate intravenous glucose-insulin-potassium (GIK) reduces ischemia-related arrhythmias and myocardial injury. Clinical trials have not consistently shown these benefits, possibly due to delayed administration.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research